Dewpoint Therapeutics GmbH

Tatzberg 47
01307 Dresden
Deutschland

Website: www.dewpointx.com

Branche:

Biotechnology

Produkte/Dienstleistungen: Drug discovery and development
Standort(e): Dresden, Frankfurt am Main, Boston
Gründungsdatum: 2018
Mitarbeiterzahl: 130
Das Unternehmen Dewpoint Therapeutics is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. We believe that a vast range of conditions arise from the dysfunction or aberrant composition of condensates (condensatopathy) — including cancer, neurodegeneration, cardiopulmonary disorders, and metabolic disease. We are employing our integrated wet lab/machine learning platform to identify a suite of condensate-modulators (c-mods) with the potential to alter the course of these diseases. Our scientists work in Boston, Dresden, and Frankfurt to translate condensate biology into treatments for the toughest diseases.
Learn more at dewpointx.com, and follow us on Twitter and LinkedIn.
Scientists or investors interested in biomolecular condensates can also visit condensates.com for news and updates in the field.

Angebotene Stellen pro Jahr: 30
Gesuchte Fachrichtungen:

Biowissenschaften 

Biochemie 

Biotechnologie 

Chemie 

Pharmazie 

Medizin

Ingenieurwissenschaften 

Informatik 

Translationale Medizin

Gesuchte Abschlüsse:

PostDoc

PhD

Master

Bachelor

Technische Assistenten

Zusatzqualifikationen (soft skills): fluent English
Einstiegsmöglichkeiten:

All levels

Traineeprogramme (Zahl der Plätze /Jahr): Nein
Kontakt: Tatzberg 47
Dewpoint Therapeutics GmbH